about
Erectile dysfunction and central obesity: an Italian perspectiveEmerging medication for the treatment of male hypogonadism.Could androgens maintain specific domains of mental health in aging men by preserving hippocampal neurogenesis?Molecular targets of androgen signaling that characterize skeletal muscle recovery and regeneration.Epigenetic mechanisms in commonly occurring cancers.Diagnosis and management of testosterone deficiencyEffects of long-term androgen replacement therapy on the physical and mental statuses of aging males with late-onset hypogonadism: a multicenter randomized controlled trial in Japan (EARTH Study).How to recognize late-onset hypogonadism in men with sexual dysfunction.Risks and benefits of late onset hypogonadism treatment: an expert opinion.Transdermal testosterone replacement therapy in men.Hypogonadism in human immunodeficiency virus-positive men.Selective androgen receptor modulators for the treatment of late onset male hypogonadism.Androgen function in the pathophysiology and treatment of male Huntington's disease patients.To treat or not to treat with testosterone replacement therapy: a contemporary review of management of late-onset hypogonadism and critical issues related to prostate cancer.The effect of hypogonadism and testosterone-enhancing therapy on alkaline phosphatase and bone mineral density.Update on Testosterone Replacement Therapy in Hypogonadal Men.The impact of age, BMI and sex hormone on aging males' symptoms and the international index of erectile function scores.Issues Surrounding Testosterone Replacement TherapyEffect of testosterone therapy on the urinary bladder in experimental hypogonadism of rats.Endocrine effects of chronic opioid therapy: implications for clinical management.Can testosterone level be a good predictor of late-onset hypogonadism?Tumor Necrosis Factor-α Impairs Kisspeptin Signaling in Human Gonadotropin-Releasing Hormone Primary Neurons.Low testosterone syndrome protects subjects with high cardiovascular risk burden from major adverse cardiovascular eventsRisk and Benefit of Androgen Deprivation Therapy in Prostate Cancer
P2860
Q22241096-A4C3C2DD-9C1D-4234-A0F5-D1DBE4991428Q34276286-4E61E0E8-0BBF-4756-AF5E-C69A4A8271A0Q34720192-8C4612A4-3D98-4AF7-9247-DDB2BE97A7BFQ36140346-FAC13896-DAB1-4EB6-80DE-FB39708BFEA2Q36286662-D84465A6-3391-4800-8E2C-9DF7ACA49639Q36293061-A40216D3-D058-4E49-8D21-D6EDDFBE5B59Q36530224-9F49D37C-AC1F-4DB1-9217-987D4E175386Q37074425-72005FD2-14D0-4F31-893C-0B62E0CE0BFDQ37165019-22E02625-14BC-4A8D-A00A-68964ED44EAEQ37478020-39606D98-AC94-4C11-A9D5-065883072992Q37500129-D1C236E9-ED65-400B-A278-33F0238BFA70Q37639204-711852DF-C258-403D-BC16-4D7C7910B949Q38016572-E3BEBE6C-32F0-4CC7-B75E-AA936A6093BAQ38212063-D7ACA4C1-FBA1-40D6-94CB-03E86FC2B409Q38232230-2539E2F2-CC7D-4D88-83D7-356C62EABD24Q38528376-85B9AE02-33C5-4AF8-B2C8-0FD14B228257Q38646373-B5F97D36-D0CD-44F6-9FCC-2E2F84F59D7FQ39225877-9A1FE077-4DA1-47C9-B10E-4E1E1DB5074FQ41168317-C1C4FE2A-A23B-4E5C-A34E-5B2DA5B23F07Q44344060-F36C8DBA-F5D2-4BFC-8EF6-DB9E0C7C8A3CQ48078158-A051EC7C-CA2C-462A-A6FF-62DC077406FAQ49233130-C64B8FD5-429B-4D21-AEC7-F534DE542922Q56973006-618D5AE5-AEB6-48AE-AFA9-20B41AC45E3DQ57582323-5861B56F-75B5-4FBC-91FF-0B65B86727F4
P2860
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on March 2011
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Update in testosterone therapy for men.
@en
Update in testosterone therapy for men.
@nl
type
label
Update in testosterone therapy for men.
@en
Update in testosterone therapy for men.
@nl
prefLabel
Update in testosterone therapy for men.
@en
Update in testosterone therapy for men.
@nl
P1476
Update in testosterone therapy for men.
@en
P2093
Gianni Forti
Giulia Rastrelli
P304
639-54; quiz 655
P356
10.1111/J.1743-6109.2010.02200.X
P577
2011-03-01T00:00:00Z